These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15535038)

  • 1. Alzheimer lesions after ischemia-reperfusion brain injury.
    Pluta R
    Folia Neuropathol; 2004; 42(3):181-6. PubMed ID: 15535038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease.
    Pluta R
    Curr Neurovasc Res; 2004 Dec; 1(5):441-53. PubMed ID: 16181092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.
    Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ
    Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease.
    Pluta R
    Ann N Y Acad Sci; 2000 Apr; 903():324-34. PubMed ID: 10818522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
    Koistinaho M; Koistinaho J
    Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide.
    Pluta R; Jabłoński M; Czuczwar SJ
    Folia Neuropathol; 2012; 50(2):101-9. PubMed ID: 22773455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
    Watt AD; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2013; 33 Suppl 1():S283-93. PubMed ID: 22699851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's factors in postischemic dementia.
    Pluta R; Ułamek-Kozioł M; Januszewski S; Sciślewska M; Bogucka-Kocka A; Kocki J
    Rom J Morphol Embryol; 2012; 53(3):461-6. PubMed ID: 22990533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease.
    Moore AH; O'Banion MK
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1627-56. PubMed ID: 12453679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.
    Ułamek-Kozioł M; Czuczwar SJ; Januszewski S; Pluta R
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease.
    Zhang Q; Gao T; Luo Y; Chen X; Gao G; Gao X; Zhou Y; Dai J
    PLoS One; 2012; 7(3):e33722. PubMed ID: 22457786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consideration of the ischaemic basis and treatment of Alzheimer's disease.
    Pluta R; Ułamek M; Jabłoński M
    Folia Neuropathol; 2010; 48(1):11-26. PubMed ID: 20383807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.